Baby Safety / Compounds / Ivermectin

Is Ivermectin safe for babies and kids?

Moderate risk for kids

Infants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Ivermectin poses heightened risk.

What is ivermectin?

Also known as: 22,23-dihydroabamectin, 22,23-dihydroavermectin b1, 22,23-dihydroavermectin b1a, 22,23-dihydro c-076b1.

CAS number
70288-86-7

Risk for babies

Moderate risk

Infants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Ivermectin poses heightened risk.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Elevated risk

Ivermectin poses pregnancy risk through potential teratogenicity, altered pharmacokinetics (increased blood volume, changed CYP activity), and placental transfer. FDA pregnancy category should be evaluated.

Suspected reproductive toxicant (GHS H361) or suspected endocrine disruptor. Precautionary approach warranted. Animal studies or limited human data suggest developmental toxicity potential.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

1 regulatory bodyhas classified Ivermectin.

AgencyYearClassificationNotes
EPA CTX / Skin-Eye—Skin Irritation: Category 6.3B (Category 3) (score: moderate)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter ivermectin

  • Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational Environments — Factories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Ivermectin:

  • Alternative drug class; Non-pharmacological therapy; Lowest effective dose
    Trade-offs: Direct chemical substitution requires verification that the replacement does not introduce new hazards (regrettable substitution). Conduct full hazard assessment of proposed alternative before adoption.
    Relative cost: 1.2-2×

Frequently asked questions

Is ivermectin safe for kids?

Infants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Ivermectin poses heightened risk.

What products contain ivermectin?

Ivermectin appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

What should I do if my child is exposed to ivermectin?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

See Ivermectin in the baby app

Look up products containing ivermectin, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (4)
  1. US FDA: Ivermectin — Approved Human Use (Onchocerciasis, Strongyloidiasis), Safety at Therapeutic Doses, Veterinary Concentration Overdose Risk, and COVID-19 Misinformation Advisory (2021) (2021) — regulatory
  2. WHO: Ivermectin — Macrocyclic Lactone Mechanism, Human Parasitic Disease Applications, Safety Profile, and Population-Level Mass Drug Administration Experience in Onchocerciasis Control Programs (2019) (2019) — regulatory
  3. ASPCA Animal Poison Control Center: Ivermectin and Macrocyclic Lactone Toxicosis in Dogs and Cats — MDR1/ABCB1 Mutation, Breed-Specific Risk, Clinical Presentation, and Lipid Emulsion Therapy (2022) (2022) — veterinary
  4. Washington State University Veterinary Clinical Pharmacology Lab: ABCB1 (MDR1) Mutation — Breed Distribution, Drug Sensitivity List Including Ivermectin and Macrocyclic Lactones, and Genetic Testing Recommendations (2023) (2023) — academic

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →